MaoXing Li Selected Research

N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamide

1/2018	Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet.
10/2017	Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

MaoXing Li Research Topics

Disease

2	Hyperglycemia 01/2018 - 10/2017
2	Insulin Resistance 01/2018 - 10/2017
2	Glucose Intolerance 01/2018 - 10/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 10/2017
1	Body Weight (Weight, Body) 01/2018
1	Obesity 10/2017

Drug/Important Bio-Agent (IBA)

2	N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA 01/2018 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2017
2	GlucocorticoidsIBA 01/2018 - 10/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2017
1	MelatoninIBA 10/2017